Estradiol is the primary circulating estrogen in reproductive-age females. A single blood concentration means very little without knowing your menopausal status, your sex, and the cycle day of your blood draw. A concentration that represents normal ovulation in a cycling woman indicates abnormal estrogen production in a child or postmenopausal adult.
The Verdict
Published Reference Ranges Across Biological Stages
Published reference intervals vary widely depending on biological sex, age, and menstrual cycle phase. Labcorp publishes specific reference intervals for its test 004515, obtained using the Roche ECLIA methodology. For adult females, the early follicular phase spans 12.5 to 166.0 pg/mL. Mid-cycle ovulation peaks higher, covering 85.8 to 498.0 pg/mL. The luteal phase drops to 43.8 to 211.0 pg/mL. After menopause, normal levels decline to less than 6.0 to 54.7 pg/mL. During the first trimester of pregnancy, values rise to between 215.0 and more than 4,300.0 pg/mL.
Adult males show a reference interval of 7.6 to 42.6 pg/mL. Male estrogen levels stay relatively steady. Men can review our guide to estradiol levels in men. Children between ages 1 and 10 display low baseline ranges. Boys range from 0.0 to 20.0 pg/mL. Girls show a published reference interval of 6.0 to 27.0 pg/mL.
Laboratories report results in either picograms per milliliter (pg/mL) or picomoles per liter (pmol/L). These units represent two entirely different measurement scales. A laboratory report prints its reference interval in the exact unit used for testing. Comparing a pmol/L result against a pg/mL reference band causes misinterpretation. Always confirm that the measured number and the reference interval match units.
| Stage or Demographic | Reference Interval (pg/mL) | Testing Methodology |
|---|---|---|
| Adult female, follicular phase | 12.5 to 166.0 pg/mL | Roche ECLIA (Labcorp) |
| Adult female, ovulation | 85.8 to 498.0 pg/mL | Roche ECLIA (Labcorp) |
| Adult female, luteal phase | 43.8 to 211.0 pg/mL | Roche ECLIA (Labcorp) |
| Adult female, postmenopausal | <6.0 to 54.7 pg/mL | Roche ECLIA (Labcorp) |
| Pregnancy, first trimester | 215.0 to >4,300.0 pg/mL | Roche ECLIA (Labcorp) |
| Adult male | 7.6 to 42.6 pg/mL | Roche ECLIA (Labcorp) |
| Children 1 to 10 years, female | 6.0 to 27.0 pg/mL | Roche ECLIA (Labcorp) |
| Children 1 to 10 years, male | 0.0 to 20.0 pg/mL | Roche ECLIA (Labcorp) |
Differences Between Estradiol and Total Estrogen Testing
An estradiol blood test measures only one specific hormone rather than your total circulating estrogen pool. According to MedlinePlus, an estrogen test measures estrogen levels in blood, urine, or saliva. The encyclopedia entry on MedlinePlus confirms that an estradiol test specifically measures the amount of estradiol in a blood sample. Test names vary across laboratories, including estrone (E1), estradiol (E2), estriol (E3), and estrogenic hormone tests.
The human body produces three major naturally occurring estrogens. Labcorp identifies these as estrone (E1), estradiol (E2), and estriol (E3). Estradiol is the predominant estrogen during reproductive years in both absolute serum concentration and biological activity. Labcorp documents that E2 demonstrates two to five times the biological potency of E1.
Menopause permanently alters this endocrine balance. A dramatic drop in ovarian E2 production leaves estrone as the predominant circulating estrogen in postmenopausal women. MedlinePlus notes that estrone is the only type of estrogen that females continue to make after menopause. Estriol serves as the main pregnancy estrogen and does not play a significant role in nonpregnant women or men.
Estrogen production relies on peripheral conversion. Ovaries and testes produce E2 primarily through the aromatization of testosterone. Adrenal glands contribute smaller amounts. Adipose tissue also converts circulating precursors into estrogens. In postmenopausal women, adipose tissue becomes a major source of estradiol.
Clinical Causes of an Elevated Estradiol Reading
Labcorp states that normal or elevated E2 accompanied by irregular or absent menstrual periods suggests polycystic ovarian syndrome, androgen-producing tumors, or estrogen-producing tumors. In adult females of childbearing age, pregnancy causes natural elevations. During the first trimester, circulating levels reach between 215.0 and more than 4,300.0 pg/mL.
Tumors originating outside the ovaries also increase circulating estrogens. The Association for Diagnostics & Laboratory Medicine (ADLM) publishes an Optimal Testing guide stating that values above the reference interval indicate estrogen excess. The ADLM panel notes that these elevated concentrations may indicate a feminizing adrenal tumor.
MedlinePlus notes that clinicians order testing to evaluate whether fertility treatments or hormone replacement therapies are functioning properly.
Earlier reproductive medicine protocols attempted to use baseline estradiol to evaluate ovarian reserve. Labcorp notes that while early studies suggested E2 levels could predict ovarian reserve in women of reproductive age undergoing assisted reproduction, more recent studies have found the marker less useful for that purpose.
Low Estradiol Readings and the Immunoassay Accuracy Floor
Low estradiol results reflect reduced ovarian production, hypothalamic suppression, or specific pharmaceutical therapies. Labcorp explains that low E2 paired with low or inappropriately normal luteinizing hormone (LH) or follicle-stimulating hormone (FSH) in young adult females indicates hypogonadotrophic hypogonadism. This suppression can result from starvation, overexercise, severe physical or emotional stress, or alcohol and drug abuse.
Primary gonadal failure represents a distinct physiological breakdown. Labcorp categorizes the causes of primary failure into genetic factors, autoimmune conditions, and toxic insults. Genetic causes include Turner syndrome and familial premature ovarian failure. Toxic insults include chemotherapy and radiation therapy. In addition, the ADLM testing guide observes that aromatase inhibitor therapies produce low values consistent with clinical estrogen deficiency.
Standard laboratory methods struggle to accurately quantify these suppressed concentrations. The ADLM Optimal Testing guide warns that immunoassay testing of estradiol is generally only appropriate for concentrations above approximately 50 pg/mL. Below that threshold, immunoassays tend to overestimate actual hormone concentrations.
This analytical limitation directly affects specific clinical populations. ADLM explicitly advises against ordering estradiol by immunoassay in men, children, and postmenopausal women. Those demographic groups require testing by sensitive liquid chromatography-tandem mass spectrometry (LC/MS). Immunoassays perform best at higher concentrations and work well for individuals in the adult-female reproductive range. Our technical guide explains the structural differences in an ultrasensitive estradiol test using LC-MS/MS platforms.
Assay Inconsistency, Biotin Interference, and Cross-Reactivity
Estradiol results generated by different laboratory platforms cannot be compared directly against each other in serial monitoring. Labcorp explicitly states that estradiol results obtained with different assay methods cannot be used interchangeably in serial testing. To monitor a patient over time, clinicians must ensure the laboratory uses the same analytical methodology for every blood draw.
Biological transitions introduce natural instability. Labcorp notes that estradiol levels fluctuate dramatically during the perimenopausal transition. The lab warns that there is significant overlap between expected postmenopausal ranges and values observed during normal menstrual cycles. Anyone navigating cycle irregularity can read our guides on the perimenopause biomarker panel and the stages of menopause.
Nutritional supplements can compromise laboratory assay chemistry. Labcorp warns that the Roche ECLIA test may exhibit analytical interference when a blood sample comes from an individual consuming high doses of biotin. The laboratory advises that patients stop taking biotin supplements for at least 72 hours prior to sample collection.
Specific pharmaceutical treatments also cause chemical cross-reactivity. Labcorp cautions that due to the risk of cross-reactivity, its standard estradiol assay should not be used when monitoring patients treated with fulvestrant. An LC/MS method should be used instead.
Blood Draw Logistics, Fasting Requirements, and Sample Timing
An estradiol blood test does not require fasting from food or water before your blood sample is collected. Routine metabolic tests require fasting, but estradiol testing does not follow those rules.
Pre-test preparation centers on medications rather than meal timing. MedlinePlus notes that you may need to stop taking certain supplements and medicines before your test. The encyclopedia entry lists birth control pills, estrogen therapies, and testosterone as examples of medications providers may ask patients to pause. You must tell your healthcare provider about everything you take. Never stop taking any prescribed medication unless your provider explicitly instructs you to do so.
Menstrual cycle timing dramatically shifts measured values in premenopausal females. Labcorp describes normal cycle dynamics: E2 levels sit lowest during the early follicular phase and rise gradually. Two to three days before ovulation, concentrations accelerate rapidly toward a pre-ovulatory peak. Values decline modestly during ovulation, rise again gradually until the midpoint of the luteal phase, and ultimately decline back to early follicular baselines.
Because concentrations shift across each cycle phase, scheduling requires careful planning. We break down the clinical logic of scheduling specific draw days in our dedicated guide to estradiol levels by cycle day.
Turnaround times vary across testing facilities. Laboratories do not publish a single universal turnaround schedule for estradiol results. Turnaround depends on whether a facility processes the immunoassay on site or routes the tube to a specialized reference laboratory for LC/MS analysis. Your ordering provider can tell you which method was ordered.
Complementary Biomarkers in Reproductive Hormone Panels
Estradiol on its own is not diagnostic. The testing guidance pairs it with total and possibly free testosterone, prolactin, FSH and LH when the question is low libido or suspected hypogonadism, and Labcorp notes that estradiol read together with FSH and anti-Müllerian hormone helps predict the timing of the menopausal transition. Our guides on the SHBG blood test and the comprehensive thyroid panel cover the two markers most often added when a result does not match the symptoms.
Clinical Indications for Testing and Physician Follow-Up
Testing your estradiol level helps clinicians investigate menstrual irregularity, monitor fertility treatments, or evaluate hormone replacement therapy. MedlinePlus outlines several distinct clinical reasons for ordering an estrogen test. For females of childbearing age, testing is indicated when periods become abnormal or cease entirely. The test also evaluates ovarian, placental, or adrenal function, screens for ovarian tumors, and tracks patient response to hormone therapy or fertility protocols. Patients monitoring active hormone treatments can explore our clinical review on whether HRT is working.
Serial assessments are often necessary to establish clinical clarity. MedlinePlus notes that females may need testing more than once to identify a trend because hormone concentrations change frequently. A healthy estrogen concentration depends on age, biological sex, the clinical reason for testing, and other concurrent lab results.
Discuss your estradiol blood test results directly with your healthcare provider to interpret your numbers within the context of your symptoms and stage of life.
Frequently Asked Questions
What is a normal estradiol level?
A normal estradiol level depends on your biological sex, your age, and your menstrual cycle phase. According to Labcorp reference ranges for test 004515 using Roche ECLIA methodology, adult cycling females range from 12.5 to 166.0 pg/mL in the follicular phase, 85.8 to 498.0 pg/mL during ovulation, and 43.8 to 211.0 pg/mL in the luteal phase. After menopause, normal levels drop to less than 6.0 to 54.7 pg/mL. Adult males have a normal range of 7.6 to 42.6 pg/mL. First-trimester pregnancy ranges from 215.0 to over 4,300.0 pg/mL. Because labs use different testing methods, compare your result against the reference interval on your specific lab report.
Is estradiol the same as estrogen?
Estradiol is one specific hormone within the broader estrogen family. The human body produces three major naturally occurring estrogens: estrone (E1), estradiol (E2), and estriol (E3). According to Labcorp, estradiol is the predominant estrogen during reproductive years in both circulating concentration and biological activity. E2 has two to five times the potency of estrone. After menopause, ovarian estradiol production drops sharply, leaving estrone as the predominant circulating estrogen. MedlinePlus notes that an estrogen test can measure total estrogens across blood, saliva, or urine, while an estradiol test specifically measures E2 in blood.
Do I need to fast for an estradiol blood test?
You do not need to fast from food or water before an estradiol blood test. However, medications and supplements require careful attention. MedlinePlus notes that you may need to pause certain medicines, such as birth control pills, hormone therapy, or testosterone, under your doctor's direction. Labcorp also recommends stopping high-dose biotin supplements at least 72 hours before testing to avoid assay interference. Always consult your healthcare provider before pausing any prescribed medication.
What does a high estradiol level mean?
A high estradiol level indicates that your body is producing or receiving elevated amounts of estrogen. In cycling females, elevated levels occur naturally during mid-cycle ovulation and pregnancy, where first-trimester levels range from 215.0 to over 4,300.0 pg/mL per Labcorp. Outside of these states, Labcorp notes that normal or high E2 with irregular periods suggests polycystic ovarian syndrome, androgen-producing tumors, or estrogen-producing tumors. The Association for Diagnostics & Laboratory Medicine notes that high values can indicate estrogen excess from feminizing adrenal tumors.
What does a low estradiol level mean?
A low estradiol level indicates reduced estrogen production by the ovaries. Labcorp states that low E2 with low or normal LH and FSH in young females is consistent with hypogonadotrophic hypogonadism caused by overexercise, starvation, stress, or substance abuse. Low levels also stem from primary ovarian failure, such as Turner syndrome, premature ovarian failure, or chemotherapy toxicity. Low levels are normal after menopause, with Labcorp citing ranges under 6.0 to 54.7 pg/mL. The Association for Diagnostics & Laboratory Medicine notes that aromatase inhibitors cause low values, and standard immunoassays often overestimate concentrations below 50 pg/mL.
How do I convert estradiol between pg/mL and pmol/L?
Laboratories report estradiol in either picograms per milliliter (pg/mL) or picomoles per liter (pmol/L), which represent two different measurement scales. Clinical reference intervals are printed in the same unit as your numerical result. No conversion factor appears on the sources behind this page, so the only safe comparison is a result against the interval printed in the same unit on the same report: a lab reporting in pmol/L prints a pmol/L interval beside it. Comparing a result recorded in pmol/L against a reference range provided in pg/mL is the most common reason a normal reading is mistakenly interpreted as abnormal. Always match your result directly to the specific unit and reference band provided by the testing laboratory.
Why did my estradiol result change so much between tests?
Estradiol concentrations fluctuate naturally across the menstrual cycle and can vary based on laboratory methodology. Labcorp notes that E2 levels rise from follicular baselines to peak rapidly before ovulation, drop modestly, rise during the luteal phase, and fall before menstruation. During perimenopause, levels tend to fluctuate dramatically. In addition, Labcorp emphasizes that estradiol results from different assay methods cannot be used interchangeably for serial monitoring. To monitor serial results, the same methodology should be used each time.
How long do estradiol blood test results take?
Laboratories do not publish a standard turnaround time for estradiol testing because processing schedules depend on the analytical method used. Turnaround depends on whether the lab runs the immunoassay in house or sends a sensitive LC/MS assay out. Your ordering healthcare provider can confirm whether an in-house immunoassay or a send-out mass spectrometry test was ordered.